Key indicators: single-crystal X-ray study; T = 296 K; mean (C-C) = 0.006 Å; disorder in main residue; R factor = 0.037; wR factor = 0.122; data-to-parameter ratio = 16.7.
In the crystal structure of the title compound, C 22 H 17 BrO 6 , the quinone ring makes a dihedral angle of 81.84 (3) with the benzene ring. The chiral C atoms, viz. the ring C atoms bearing the hydroxy and bromophenyl substituents, exhibit R and S configurations, respectively. The terminal ethyl group of the -CO 2 CH 2 CH 3 group is disordered over two sets of sites with site-occupancy factors of 0.64 (1) and 0.36 (1). Intermolecular O-HÁ Á ÁO interactions further stabilize the crystal packing. Table 1 Hydrogen-bond geometry (Å , ). 
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Comment
The Michael addition to α, β-unsaturated systems is an important carbon-carbon bond-forming reaction in organic synthesis. Hydroxyquinones, quinones bearing a hydroxy group on the quinone ring, are an important class of the naturally occurring quinones with diverse biological activity. The title compound, ethyl (2S,4R)-4-(4-bromophenyl)-2-hydroxy-5,10-dioxo-3,4,5,10-tetrahydro-2H-benzo[g]chromene-2-carboxylate, was synthesized from a Michael Addition of 2-hydroxy-1,4-naphthoquinone to β,γ-unsaturated α-keto esters. The crystal structure of the title compound ( Fig. 1) contains a tricyclic ring system with two chiral centers, which is consisting of a quinone ring and a tetrahydropyrane. One carbon atom of the tetrahydropyrane structure is not coplanar with the backbone, lying 0.554 (4) Å from the mean plane of the rest backbone.
The terminal ethyl group of CO 2 CH 2 CH 3 is disordered over two sites with site occupancy factors of 0.64 (1) and 0.36 (1).
Moreover, weak O-H···O and C-H···O intermolecular interactions further stabilize the crystal structure.
Experimental
To a solution of (E)-ethyl 4-(4-bromophenyl)-2-oxobut-3-enoate (1 mmol) and 2-hydroxy-1,4-naphthoquinone (1 mmol) in 1,4-dioxane (3 ml) was added 3-((1S)-(6-methoxyquinolin-4-yl) (8-vinylquinuclidin-2-yl)methylamino)-4-((S)-1-phenylethylamino)cyclobut -3-ene-1,2-dione (0.025 mmol) as catalyst, and the mixture was stirred at room temperature for 
